Navigation Links
2008 Signature Genomic Laboratories Travel Award presented
Date:4/2/2008

Madhuri R. Hegde, PhD, FACMG was honored as the 2008 recipient of the Signature Genomic Laboratories Travel Award at the American College of Medical Genetics (ACMG) 2008 Annual Clinical Genetics Meeting in Phoenix, AZ. Dr. Hegde is Assistant Professor, Department of Human Genetics and Director of the DNA Diagnostic Laboratory at Emory University School of Medicine.

New in 2008, the Signature Genomics Travel Award is given to a selected student, trainee or junior faculty ACMG member whose abstract submission was chosen as a platform presentation during the 2008 ACMG Annual Clinical Genetics Meeting. The program committee selects the Travel Award recipient based on scientific merit. In recognition of the selected presentation, Signature Genomics covers the travel costs for the recipient to the ACMG meeting.

The American College of Medical Genetics Foundation is grateful to Signature Genomics for their generous support of up-and-coming medical genetic researchers through the new Signature Genomics Travel Award, said R. Rodney Howell, MD, FACMG, president of the ACMGF.

Signature supports the recognition of outstanding young researchers in the field of medical genetics, said Lisa G. Shaffer, PhD, president and CEO of Signature Genomics. We are proud to be sponsoring this award.


'/>"/>

Contact: Kathy Ridgely Beal
kbeal@acmg.net
301-238-4582
American College of Medical Genetics
Source:Eurekalert

Page: 1

Related biology news :

1. Entrust Digital Signatures Help Secure More Than 18 Million U.S. ePassports
2. Genes selective signature aids detection of natural selection in microbial evolution
3. DNA replication behavior in complex organisms may foreshadow leaps in genomic discoveries
4. UCI and CODA Genomics collaborate to re-engineer yeast for biofuel production
5. Metagenomics of the deep Mediterranean
6. Metagenomics of the deep Mediterranean
7. Inconsistencies with Neanderthal genomic DNA sequences
8. Microarray sequence capture speeds large-scale resequencing of targeted genomic regions
9. NYUs Center for Genomics & Systems Biology receives $4.4 million NSF grant
10. Human RecQ helicases, homologous recombination and genomic instability
11. Virginia Tech plant scientist leads study on genomics of parasitic plants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
(Date:3/31/2016)...  Genomics firm Nabsys has completed a financial  restructuring ... , M.D., who returned to the company in October ... team, including Chief Technology Officer, John Oliver , ... and Vice President of Software and Informatics, Michael ... Dr. Bready served as CEO of Nabsys from 2005-2014 ...
(Date:3/22/2016)... , PROVO and ... Newborn Screening Ontario (NSO), which operates the highest sample ... molecular testing, and Tute Genomics and UNIConnect, leaders in ... respectively, today announced the launch of a project to ... (NGS) testing panel. NSO has been ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal articles ... findings are the subject of a new article on the Surviving Mesothelioma website. ... blood, lung fluid or tissue of mesothelioma patients that can help point doctors to ...
(Date:6/23/2016)... WI (PRWEB) , ... June 23, 2016 , ... ... supplements, is pleased to announce the launch of their brand, UP4™ Probiotics, into ... for over 35 years, is proud to add Target to its list of ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology: